|
|
||||||||
MICROBIAL ECOLOGY |
MRC Microbiology and Gut Biology Group, University of Dundee Medical School, Dundee, DD1 9SY
Correspondence to: Dr M. J. Hopkins (e-mail: m.j.hopkins{at}dundee.ac.uk).
Received 31 Oct. 2001; accepted 16 Dec. 2001.
Abstract
The bacterial composition of human faeces can vary greatly with factors such as age and disease, although relatively few studies have monitored these events, particularly at species level. In this investigation, bacteria were isolated from faecal samples from healthy young adults and elderly subjects, and elderly patients with Clostridium difficile-associated diarrhoea (CDAD). The organisms were identified to species level on the basis of their cellular fatty acid profiles with the MIDI system. In some groups of bacteria, species diversity was found to change with age despite the overall numbers of organisms being similar at genus level. Bacteroides thetaiotaomicron, B. ovatus and Prevotella tannerae were common gram-negative anaerobes isolated from young adults. Bacteroides species diversity increased in the faeces of healthy elderly people. Bifidobacterial species diversity decreased with age, with Bifidobacterium adolescentis and Bif. angulatum being the most common isolates. CDAD patients were characterised by greater diversity of facultative species, lactobacilli and clostridia, but greatly reduced numbers of bacteroides, prevotella and bifidobacteria. Such bacterial population changes in the normal microbiota could result in metabolic conditions favourable for the establishment of pathogenic micro-organisms, such as clostridia, and would have considerable effects on the biochemical capacity of the large intestine as a whole. Alterations in the community structure of bifidobacteria and lactobacilli have relevance for dietary and therapeutic interventions such as the use of pre- or probiotics that aim to modify the composition or metabolic activities of the intestinal microflora in a beneficial way, particularly in elderly people or individuals at risk of CDAD.
This article has been cited by other articles:
![]() |
P.-Y. Hong, J.-H. Wu, and W.-T. Liu Relative Abundance of Bacteroides spp. in Stools and Wastewaters as Determined by Hierarchical Oligonucleotide Primer Extension Appl. Envir. Microbiol., May 1, 2008; 74(9): 2882 - 2893. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Tuohy Inulin-Type Fructans in Healthy Aging J. Nutr., November 1, 2007; 137(11): 2590S - 2593S. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Wexler Bacteroides: the Good, the Bad, and the Nitty-Gritty Clin. Microbiol. Rev., October 1, 2007; 20(4): 593 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Segarra-Newnham Probiotics for Clostridium difficile-Associated Diarrhea: Focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii Ann. Pharmacother., July 1, 2007; 41(7): 1212 - 1221. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. RANI, R.S. MURTHY, S. BHATTACHARYA, V. AHUJA, M.A. RIZVI, and J. PAUL CHANGES IN BACTERIAL PROFILE DURING AMEBIASIS: DEMONSTRATION OF ANAEROBIC BACTERIA IN ALA PUS SAMPLES Am J Trop Med Hyg, November 1, 2006; 75(5): 880 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Akerlund, B. Svenungsson, A. Lagergren, and L. G. Burman Correlation of Disease Severity with Fecal Toxin Levels in Patients with Clostridium difficile-Associated Diarrhea and Distribution of PCR Ribotypes and Toxin Yields In Vitro of Corresponding Isolates J. Clin. Microbiol., February 1, 2006; 44(2): 353 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mueller, K. Saunier, C. Hanisch, E. Norin, L. Alm, T. Midtvedt, A. Cresci, S. Silvi, C. Orpianesi, M. C. Verdenelli, et al. Differences in Fecal Microbiota in Different European Study Populations in Relation to Age, Gender, and Country: a Cross-Sectional Study Appl. Envir. Microbiol., February 1, 2006; 72(2): 1027 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. van Tongeren, J. P. J. Slaets, H. J. M. Harmsen, and G. W. Welling Fecal Microbiota Composition and Frailty Appl. Envir. Microbiol., October 1, 2005; 71(10): 6438 - 6442. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J Lawrence, J. R Korzenik, and L. M Mundy Probiotics for recurrent Clostridium difficile disease J. Med. Microbiol., September 1, 2005; 54(9): 905 - 906. [Full Text] [PDF] |
||||
![]() |
S. D. Baines, J. Freeman, and M. H. Wilcox Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model J. Antimicrob. Chemother., June 1, 2005; 55(6): 974 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Woodmansey, M. E. T. McMurdo, G. T. Macfarlane, and S. Macfarlane Comparison of Compositions and Metabolic Activities of Fecal Microbiotas in Young Adults and in Antibiotic-Treated and Non-Antibiotic-Treated Elderly Subjects Appl. Envir. Microbiol., October 1, 2004; 70(10): 6113 - 6122. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Frankenfeld, C. Atkinson, W. K. Thomas, E. L. Goode, A. Gonzalez, T. Jokela, K. Wahala, S. M. Schwartz, S. S. Li, and J. W. Lampe Familial Correlations, Segregation Analysis, and Nongenetic Correlates of Soy Isoflavone-Metabolizing Phenotypes Experimental Biology and Medicine, October 1, 2004; 229(9): 902 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bartosch, A. Fite, G. T. Macfarlane, and M. E. T. McMurdo Characterization of Bacterial Communities in Feces from Healthy Elderly Volunteers and Hospitalized Elderly Patients by Using Real-Time PCR and Effects of Antibiotic Treatment on the Fecal Microbiota Appl. Envir. Microbiol., June 1, 2004; 70(6): 3575 - 3581. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kojima, M. W. Musch, M. J. Ropeleski, D. L. Boone, A. Ma, and E. B. Chang Escherichia coli LPS induces heat shock protein 25 in intestinal epithelial cells through MAP kinase activation Am J Physiol Gastrointest Liver Physiol, April 1, 2004; 286(4): G645 - G652. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Pei, E. J. Bini, L. Yang, M. Zhou, F. Francois, and M. J. Blaser Bacterial biota in the human distal esophagus PNAS, March 23, 2004; 101(12): 4250 - 4255. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ozaki, H. Kato, H. Kita, T. Karasawa, T. Maegawa, Y. Koino, K. Matsumoto, T. Takada, K. Nomoto, R. Tanaka, et al. Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization J. Med. Microbiol., February 1, 2004; 53(2): 167 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J.F. Pinto, A. P.P. Alcides, E. O. Ferreira, K. E.S. Avelar, A. Sabra, R. M.C.P. Domingues, and M. C. S. Ferreira Incidence and importance of Clostridium difficile in paediatric diarrhoea in Brazil J. Med. Microbiol., December 1, 2003; 52(12): 1095 - 1099. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Freeman, F. J. O'Neill, and M. H. Wilcox Effects of cefotaxime and desacetylcefotaxime upon Clostridium difficile proliferation and toxin production in a triple-stage chemostat model of the human gut J. Antimicrob. Chemother., July 1, 2003; 52(1): 96 - 102. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |